Navigation Links
California Physical Therapy Association Strongly Supports the "Promoting Integrity in Medicare Act" to Fight Self-Referral of Physical Therapist Services
Date:8/2/2013

SACRAMENTO, Calif., Aug. 2, 2013 /PRNewswire/ -- On behalf of physical therapists throughout the state, the California Physical Therapy Association (CPTA) strongly supports the Promoting Integrity in Medicare Act introduced by Representative Jackie Speier (D-CA).  The legislation, limited to Medicare, calls for eliminating the in-office ancillary services (IOAS) exception to the Federal Stark laws, including self-referral of physical therapy, advanced imaging, anatomical pathology and radiation oncology services. Backed by the American Physical Therapy Association (APTA) and the Alliance for Integrity in Medicare (AIM) coalition, the legislation is intended to eliminate financial incentives from the physician referral process. The IOAS exception was originally intended for same-day services that were fundamental to a physician's services and offered for patient convenience; however, physical therapist services do not meet the intent of the IOAS exception. Recently, the Government Accountability Office conducted studies on the economic and clinical impact of physician self-referral arrangements on health services, including advanced diagnostic imaging and anatomic pathology, and found over utilization of services and unnecessary treatments billed to Medicare.

Following APTA's announcement, Dr. James Syms, PT, DSc, ATC, SCS and President of CPTA, issued this statement:

"On behalf of all California physical therapists, CPTA believes patients have the right to choose their providers, and we strongly support the Promoting Integrity in Medicare Act.

"We have known and consistently stated that the issue of self-referral of physical therapist services would be advanced by federal policymakers and backed by strong national and state support.

"This legislation represents a significant step forward in reducing self-referral of physic
'/>"/>

SOURCE California Physical Therapy Association
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. BIT Group Restructure Will Consolidate California Facilities to Form BIT USA Inc.
2. Novel study using new technologies outlines importance of California condor social groups
3. Funding Tomorrow's Biomedical Research: California Healthcare Institute Hosts Pipeline for Life, July 15
4. AB 1000 Clears California Assembly Floor and Cited as Historic Compromise
5. U.S. Congressman John Campbell Speaks at Southern California TechVoice Breakfast on May 10
6. Californians Step Closer to Benefiting from Direct Access to Physical Therapist Services
7. Pesticide-Exempt Bed Bug Spray Samples Offered to Northern California Residents as Bed Bugs Remain a Trouble in the Area
8. ClearPath Workforce Management CEO Appointed Co-chair of Northern California Leadership Forum for Woman Owned Business Alliance
9. California Healthcare Institute Announces Executive Promotion
10. Benitec Selects University of California, San Diego as a Site for Phase I/II Clinical Trial of TT-034 in Patients with Hepatitis C Infections
11. California Healthcare Institute Appoints Associate Director, Federal Government Relations and Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... DIEGO , March 3, 2015  Neurocrine Biosciences, ... Kevin Gorman , President and Chief Executive Officer ... Global Healthcare Conference in Miami.   The ... 10:15am ET (7:15am PT).  The presentation will be webcast ... http://www.neurocrine.com .   Listeners are encouraged ...
(Date:3/3/2015)... 2015  Regenicin, Inc. (OTC Bulletin Board: ... of and commercialization of regenerative cell therapies to restore ... that it has received the final payment to conclude ... (OTC Bulletin Board: AMBS ). ... final payments due to Regenicin in the amount of ...
(Date:3/3/2015)... , March 3, 2015  Thingee Corporation, a ... be delivering a presentation entitled, "Technology Adoption: Making Reps, ... Thriving through Innovations and Technology ,  in ... 11 to 13, 2015. Audiences looking to learn how ... will want to be in the audience for the ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Genedata, ... drug discovery and life science research, today announced ... (TM) enterprise platform for use at Pfizer biopharma ... Europe. Genedata is supporting Pfizer’s global deployment and ... (GBT), Centers for Therapeutic Innovation (CTI), and Pharmaceutical ...
Breaking Biology Technology:Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 2Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 3Thingee to present at 11th Annual Synergistix Users Conference 2Genedata Biologics Licensed by Pfizer Inc. 2Genedata Biologics Licensed by Pfizer Inc. 3
... INTRODUCTION , ... which hydrolyze β -lactam antibiotics. The majority of β -lactamases produced ... to combating the serine active site β -lactamases is the use ... a β -lactam antibiotic 4 . , There is also a ...
... McGown, Ph.D. and Anna Lam, B.S., ... Molecular Devices Corporation, 8/99 , , INTRODUCTION ... use synthetic chromogenic or flu-orogenic peptide substrates. Enzyme selectivity is ... catalytic site of a particular enzyme. The chromophore or fluorophore ...
... Vronique Brechler, David Handfield, Martin Boissonneault, Esther Tremblay, ... Introduction , ... led to an unprecedented increase in both the number of compounds ... automated liquid handling and microplate assay systems has helped to meet ...
Cached Biology Technology:A Microtiter-based Assay for the Determination of ID50s of b-lactamase Inhibitors Employing Reporter Substrates Detected at UV or Visible Wavelengths (MaxLine Application Note #20) 2A Microtiter-based Assay for the Determination of ID50s of b-lactamase Inhibitors Employing Reporter Substrates Detected at UV or Visible Wavelengths (MaxLine Application Note #20) 3A Microtiter-based Assay for the Determination of ID50s of b-lactamase Inhibitors Employing Reporter Substrates Detected at UV or Visible Wavelengths (MaxLine Application Note #20) 4A Microtiter-based Assay for the Determination of ID50s of b-lactamase Inhibitors Employing Reporter Substrates Detected at UV or Visible Wavelengths (MaxLine Application Note #20) 5A Microtiter-based Assay for the Determination of ID50s of b-lactamase Inhibitors Employing Reporter Substrates Detected at UV or Visible Wavelengths (MaxLine Application Note #20) 6Fluorometric Protease Assays in the SpectraMax Gemini Microplate Spectrofluorometer: Example Using Caspase3 (MaxLine Application Note #35) 2Fluorometric Protease Assays in the SpectraMax Gemini Microplate Spectrofluorometer: Example Using Caspase3 (MaxLine Application Note #35) 3Fluorometric Protease Assays in the SpectraMax Gemini Microplate Spectrofluorometer: Example Using Caspase3 (MaxLine Application Note #35) 4Fluorometric Protease Assays in the SpectraMax Gemini Microplate Spectrofluorometer: Example Using Caspase3 (MaxLine Application Note #35) 5Fluorometric Protease Assays in the SpectraMax Gemini Microplate Spectrofluorometer: Example Using Caspase3 (MaxLine Application Note #35) 6Development of Radioligand Binding Assays for the Motilin Receptor Using ScreenReady Targets. 2Development of Radioligand Binding Assays for the Motilin Receptor Using ScreenReady Targets. 3Development of Radioligand Binding Assays for the Motilin Receptor Using ScreenReady Targets. 4Development of Radioligand Binding Assays for the Motilin Receptor Using ScreenReady Targets. 5
(Date:2/11/2015)... February 11, 2015 ... "Access Control Market by Product (Cards and Readers, Biometrics, ... Defense, Government, Industrial, Healthcare, Education) and By Geography - Global ... MarketsandMarkets, the Access Control Market is expected ... at a CAGR of 10.6% between 2014 ...
(Date:2/5/2015)... 5, 2015  Marken is starting its 35 th ... launched a new marketing campaign to solidify its place ... new campaign focuses on First as a ... The first headline in the series, ... with its client,s priorities. Marken recognizes the need to ...
(Date:2/5/2015)... -- New Market Research Reports Title Global ... 2020 has Been Added to GrandViewReseach.com Report Database ... reach USD 5.10 billion by 2020, according to a ... help identify the site of tissue damage in case ... in medical imaging applications. They have been extensively used ...
Breaking Biology News(10 mins):Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken Launches New Patient-Centric Campaign 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3
... book titles to real estate developments, it,s easier to find ... it. That,s why a Kansas State University geographer is ... who might be trying to work toward it. Her goal ... have to make decisions about what to sustain with the ...
... WASHINGTONThe Wilson Center,s Synthetic Biology project recently ... One will support a Transatlantic Exploratory Workshop on ... and Policy, and the other will support research ... explore emerging issues in synthetic biology. The ...
... Ariz. (Sept. 22, 2009) TGen Clinical Research Services ... clinical trial for a drug designed to combat adrenocortical ... the adrenal glands. TCRS is a strategic alliance ... Healthcare. Other than surgery, the only treatment for ...
Cached Biology News:K-State geographer working to clarify what sustainability really means to rural decision-makers 2Revolutionary drug could be new hope for adrenal cancer patients 2Revolutionary drug could be new hope for adrenal cancer patients 3
IMAGEQUANT 400 WKSTN, 1 EA. Category: ImageQuant CCD Imagers....
PAb to Hu-IFN-Alpha/Beta R2 [(IFNAR2) CD118], Rabbit Serum, neutralizing Binds to but does not neutralize human interferon alpha/beta receptor...
ANTI MYCOBACTERIUM TUBERCULOSIS...
ImageQuant 400, 1 EA. Category: ImageQuant CCD Imagers....
Biology Products: